Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
about
Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesLong-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivaxSimultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab.Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRemoval of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.Diagnosis and treatment of antibody-mediated kidney allograft rejection.The clinical application of monoclonal antibody therapies in renal transplantation.Tolerogenic therapies in transplantation.Carbohydrates in xenotransplantation.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.Novel treatment for immune neuropathies on the horizon.B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.Xenotransplantation: immunological hurdles and progress toward tolerance.The pathobiology of pig-to-primate xenotransplantation: a historical review.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.The effect of desensitization protocols on human splenic B-cell populations in vivo.
P2860
Q28080994-F15C0104-DEB9-4ED5-9D0E-8B5758330D73Q33533328-5A5E8350-3B80-46C1-BB4F-F2251E931E6FQ33599297-66B2D309-F6D8-451C-B378-D111C38E0AA9Q33781179-B999CB02-154C-4344-AC61-C33FCD6961E7Q34818025-0425D874-C701-4670-8C27-D28738BE0E98Q35554487-93244575-5C8C-4A1C-A6BB-F21B040C511FQ35779272-666F3770-8BEE-4528-BDBE-80FD36FB7F73Q36102133-D0AD4A3C-E279-45E5-A74F-01629F0BEFBCQ36201681-483DD9AA-2097-4925-9F95-571FD4341B1CQ36897408-68BBC6BB-5A48-4965-9FDC-CF272BF029D4Q37361071-0ACD0DDE-0CCF-436F-A733-3C1FCFB8F1E6Q37892641-1FE2B855-4C6D-4583-87CD-52A15531F773Q38097170-FE42F42E-679C-4474-B9CD-032108FCC2F8Q38187179-3EBAC29D-875F-4803-AF18-52D5E50121C9Q38712532-741D0343-8BE7-4B8C-A2BC-4A3E5CFC79C8Q42372842-A2089D4B-2419-42DD-88FE-215C2BB7210EQ50850551-DA2661D1-0893-4950-B0D3-BE2C03CEE221Q53575915-A0C4A2BC-0798-4174-AD42-401414D5F5F9
P2860
Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Effects of specific anti-B and ...... ion of anti-alphaGal antibody.
@en
type
label
Effects of specific anti-B and ...... ion of anti-alphaGal antibody.
@en
prefLabel
Effects of specific anti-B and ...... ion of anti-alphaGal antibody.
@en
P2093
P2860
P1433
P1476
Effects of specific anti-B and ...... ion of anti-alphaGal antibody.
@en
P2093
Kitamura H
Lambrigts D
P2860
P304
P356
10.1034/J.1399-3089.2001.008003157.X
P577
2001-08-01T00:00:00Z